"Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma"

If you are interested in learning more about this trial, ResearchMatch can help by contacting the trial team for you. If you’re not a volunteer yet, you’ll first need to join ResearchMatch before we can share your contact information with the research team.